Mini-Focus Issue: Insights From Acute Heart Failure TrialsClinical ResearchLevosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial
Clinical Research
Under a Creative Commons license
open access
Central Illustration
Key Words
exercise
heart failure with preserved ejection fraction (HFpEF)
hemodynamics
levosimendan
pulmonary hypertension
Abbreviations and Acronyms
CO
cardiac output
CVP
central venous pressure
HF
heart failure
HFpEF
heart failure with preserved ejection fraction
MMRM
mixed-effects model with repeated measurements
PCWP
pulmonary capillary wedge pressure
PH
pulmonary hypertension
PH-HFpEF
pulmonary hypertension in the setting of heart failure with preserved ejection fraction
PVR
pulmonary vascular resistance
SVR
systemic vascular resistance
Cited by (0)
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.